ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

Study Links Ovarian Cancer To Hormone Replacement

May 25, 2007

In Brief: MB Withdraws From Fight Over Funding New Constructions, Tosses The Ball To Ted Cooper

January 9, 1976